Abstract | BACKGROUND AND AIMS: METHODS AND RESULTS: Four NPC1L1 variants (-133A>G, -18C>A, 1679C>G, 28650A>G) were analyzed in 271 (155 women and 116 men) ADH bearers without mutations in LDLR or APOB aged 30-70years and 274 (180 women and 94 men) control subjects aged 25-65years. The AC haplotype determined by the -133A>G and -18C>A variants was underrepresented in ADH subjects compared to controls (p=0.01). In the ADH group, cholesterol absorption/synthesis markers were significantly lower in AC homozygotes that in all others haplotypes. Electrophoretic mobility shift assay (EMSA) results revealed that the -133A-specific oligonucleotide produced a retarded band stronger than the -133G allele. Luciferase activity with NPC1L1 -133G variant was 2.5-fold higher than with the -133A variant. CONCLUSION: The -133A>G polymorphism exerts a significant effect on NPC1L1 promoter activity. NPC1L1 promoter variants might explain in part the hypercholesterolemic phenotype of some subjects with nonLDLR/nonAPOB ADH.
|
Authors | B Martín, M Solanas-Barca, A-L García-Otín, S Pampín, M Cofán, E Ros, J-C Rodríguez-Rey, M Pocoví, F Civeira |
Journal | Nutrition, metabolism, and cardiovascular diseases : NMCD
(Nutr Metab Cardiovasc Dis)
Vol. 20
Issue 4
Pg. 236-42
(May 2010)
ISSN: 1590-3729 [Electronic] Netherlands |
PMID | 19747803
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2009 Elsevier B.V. All rights reserved. |
Chemical References |
- Apolipoproteins B
- Cholesterol, Dietary
- Lipids
- Membrane Proteins
- Membrane Transport Proteins
- NPC1L1 protein, human
- Receptors, LDL
- Sterols
- Luciferases
|
Topics |
- Adult
- Aged
- Apolipoproteins B
(genetics)
- Cell Line
- Cholesterol, Dietary
(pharmacokinetics)
- Electrophoretic Mobility Shift Assay
- Female
- Genes, Dominant
- Genetic Variation
- Haplotypes
- Humans
- Hyperlipoproteinemia Type II
(genetics)
- Lipids
(blood)
- Luciferases
(genetics)
- Male
- Membrane Proteins
(genetics)
- Membrane Transport Proteins
- Middle Aged
- Plasmids
(genetics)
- Polymorphism, Genetic
(genetics)
- Promoter Regions, Genetic
(genetics)
- Receptors, LDL
(genetics)
- Sterols
(blood)
- Transfection
|